Tata firm, CSIR lab develop Feluda, world’s first CRISPR based COVID-19 test kit
India’s efforts against COVID-19 saw a major fillip when the regulator, Drug Controller General of India (DCGI) gave permission for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) COVID-19 test on September 19. The test is names “Feluda'.
CRISPR, the revolutionary genetic "scissors," honored by Chemistry Nobel
The award went jointly to Dr Emmanuelle Charpentier of Max Planck Unit for the Science of Pathogens and Dr Jennifer A. Doudna of the University of California, Berkeley, "for the development of a method for genome editing."
UK firm Native Antigen launches 10 new MABs reagents for COVID-19 detection kits
Ten new monoclonal antibodies recognize distinct Spike protein epitopes on SARS-CoV-2 and the antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein. Different epitopes support identification of matched-pair reagents for immunoassay development
Students from UP, Finland win first Biotech Online poster competition organized by Karnataka Government
The Biotech Online poster presentation organized jointly by K-Tech, Association of Biotechnology Led Enterprises (ABLE) and media platform, Biotecnika and Stempeutics, was done completely online in the last week of September.
Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
ABLE Member and Hyderabad-headquartered pharma major Aurobindo Pharma announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.